Because even after today's 25% haircut, its a easy and hassle free short since blackuery days at $50 two years ago. Shorted twtr at ~52 and ~51- thanks to daytraders for bumping up. expect tomorrow trading in mid 40. I looke forward for collecting my pay cheque at low 30 within 1-2 months.
Sentiment: Strong Sell
this will run to $300, if insiders don't sale,
this will be another TASR- 100 bagger stock, which went from $1 to $100 in one year
The term "H1" and "H2" is commonly referred when companies report earnings or sales projection report.
H1 and H2 stand for "half first" and "half second" of a particular year. For example, "H12012" means first half of the year 2012, that is during January and June 2012.
Sometimes the year is divided into quarters and refered as Q1, Q2, Q3 and Q4.
Pacritinib preliminary results for phase 3 will be in H2.
The street reckons that results have a reasonable likelihood to be positive, as phase 2 was strong and convincing. So the stock will run to $7-10 in anticipation, resulting in a market cap around 700mln -1bl and if results are positives CTIC will double or triple from there.
Note that INCY with similar to Pacritinib but inferior drug has market cap 10 bln
Sentiment: Strong Buy
"For example, all of those new clients and no mention of the ONE client that is leaving with 25% of revenue."
whats you source, is that from your short imagination?
Sentiment: Strong Buy
who are competitors and whats the invention? What is you price target, if its patented, could that be a blockbuster - as TASR went from $1 to $100
a fat FDA spokesman sung, CHTP is likely to be rejected, share price collapse to 60 c. I sold and bought CDTI, already up, ten bagger , will recover loss and more- check out
I went short 90 k shares at 2.37, after reading your maniac-relentless posts and your oldtimer looking backward expertise. Now its 2.85, what should I do, cover or short more. Would you compensate if I lose?
I listed to your maniac- relentless postings with backward looking wisdom and and went short - 90 k shares at 2.35. Stock is at 2.85, I am badly down. Please, what should I do. Should I short more? If i lose, would you compensate?
Your news from 2012 are old, latter in 2013 FDA changed their mind and said it will consider approval with subsequent post marketing study
February 20, 2013
Chelsea Therapeutics Receives FDA Guidance for a Northera(TM) (Droxidopa) NDA Resubmission With Study 306B
Company to Resubmit NDA in Late Second Quarter 2013
Short-term Clinical Benefit Adequate to Support Approval
Company to Host Conference Call Today at 9:00 AM ET
CHARLOTTE, N.C., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced that it has received written guidance from the Director of the Office of New Drugs ("the Director") at the U.S. Food and Drug Administration (FDA) stating that Study 306B has the potential to serve as the basis for a resubmission of a Northera™ (droxidopa) New Drug Application (NDA) for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). The guidance is in response to a formal appeal by Chelsea to the Director, and follows a meeting with the Director and top staff from the Office of Drug Evaluation I and Division of Cardiovascular and Renal Products (DCRP) at the FDA's Center for Drug Evaluation and Research.
The guidance suggests that "data strongly demonstrating a short-term clinical benefit (e.g., improvement in symptoms or ability to function) of droxidopa in patients with NOH would be adequate for approval, with a possible requirement to verify durable clinical benefit post-approval." It further notes that any decision regarding the outcome of an FDA review, to be performed by the DCRP will be based on the strength of Study 306B and its ability to provide substantial evidence of effectiveness to support approval.
i am serious, if you are chronic pain patient or know someone who is, you should defend Zahydro as newly approved treatment option available to you. Rather then sitting on yahoo message board, write to FDA. FDA would really appreciate your support , remember FDA is in your side. If your writing skill are good, you may even became famous, if your letter quoted in national press.
Sentiment: Strong Buy
what's market cap of this stock, or in other words how many shares are outstanding. I obviously mean including preference A,B,C,D etc. Has anyone managed to convert all preferences shares into ordinary and see how many shares are available after conversion? thanks
dead money for the next 2-3 months, will start running next spring, imo